Patient Centered Outcomes HTA, TA Director
Join to apply for the Patient Centered Outcomes HTA, TA Director role at Novartis
Summary
As part of International HEOR & PCO in International Value & Access, the Patient Centered Outcomes (PCO) HTA, TA Director collaborates with HEOR leads to co‑lead the PCO reimbursement strategy that enables patient‑centered outcome measurements to support robust payer value propositions and HTA evidence, optimizing international access for prioritized Novartis assets. The role oversees one therapeutic area (e.g., CRM, immunology, oncology, or neurosciences) and spans multiple assets/indications, guiding the HEOR TA team in developing Health Technology Assessment Strategy Plans and Integrated Evidence Plans. The Director serves as an internal expert on health utility assessment, leads health state valuation projects (Time Trade‑Off or Standard Gamble studies), supports early scientific advice with HTA agencies, and represents Novartis externally with industry consortiums and stakeholders.
Key Responsibilities
* Co‑lead with the HEOR TA lead the development, delivery, and communication of a compelling PCO reimbursement strategy within the HTAP, IPAS, 1BP, and aligned with the Integrated Evidence Plan.
* Partner with the PCO COE, Global Program Teams, HEOR Leads, HTA Evidence Synthesis, Access, Medical Affairs, and AQS Biostat to ensure the PCO measurement strategy includes patient‑reported outcomes and health utilities relevant for international HTAs and payers within the clinical development program.
* Participate in and co‑lead projects on behalf of the OnePCO Alignment Forum to ensure PCOs critical for HTAs and payers are included in clinical trials, non‑interventional studies, and real‑world studies for selected assets, coordinating with countries to align on local HTA and payer needs.
* Drive understanding of HTA requirements for PCO, health utility assessment, and adoption of standards and best practices by key markets.
* Lead health state valuation projects via development and management of Time Trade‑Off (TTO) or Standard Gamble (SG) studies where appropriate.
* Assist in scientific discussions with HTA agencies, particularly providing scientific advice from entities such as EU HTA JSC, NICE, CADTH, and preparing briefing documents and dossiers to include a robust patient value proposition.
* Develop a strategic scientific communication plan, including submission and presentation of research in peer‑reviewed journals and scientific/methodological congresses.
* Engage with external thought leaders, identify research collaborations, and represent Novartis with external stakeholders (academic institutions, HTA agencies) to monitor and shape the external environment regarding patient‑centered outcomes research.
* Lead above‑brand research projects and initiatives to pilot innovative methodologies for value demonstration and elevate internal standards/best practices within International Value & Access and at Novartis with cross‑functional partners.
Essential Requirements
* 8+ years of Pharma industry experience with at least 5 years in HEOR roles, including a minimum of 3 years leading health utility projects.
* Advanced degree in a relevant field.
* Experience evaluating, developing, and validating PRO/PCO instruments to meet HTA reimbursement requirements.
* In‑depth knowledge of key patient‑centered outcome measurement systems (e.g., EuroQoL, Quality Metric Short‑Form, HUI).
* Strong cross‑functional leadership and collaboration skills.
* Ability to manage multiple priorities in a rapidly changing environment.
* Ability to work collaboratively to leverage other HEOR capabilities (strategy, regions, countries, COE PCO).
Desirable Requirements
* Ph.D., M.D., MBA, MSc, or equivalent. Strong external interface network: KOLs, clinical research & scientific groups, payers, and policy organizations.
* Experience conducting and evaluating PCO measures from conceptualization through negotiation with international health authorities and HTA submissions.
Location
This role can be based in the UK (London) but also in Dublin, Ireland or Basel, Switzerland.
Benefits
Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: Novartis Life Handbook.
Commitment to Diversity & Inclusion
Novartis is committed to building an outstanding, inclusive work environment and diverse teams representative of the patients and communities we serve.
Why Novartis
Helping people with disease and their families takes more than innovative science. It takes a community of smart, passionate people like you. Collaborating, supporting, and inspiring each other can achieve breakthroughs that change patients’ lives.
Benefits and Rewards
Read our handbook to learn about all the ways we’ll help you thrive personally and professionally: https://www.novartis.com/careers/benefits-rewards
#J-18808-Ljbffr